Diazoxide, KIR6.x (ATP-sensitive K+ channel) activator
Be the first to review this product! Submit a review
|
(1 Publication)
MW 230.67 Da, Purity >99%. Selective KIR6.x (KATP) activator; antihypertensive. Achieve your results faster with highly validated, pure and trusted compounds.
View Alternative Names
ABC36, ABCC8_HUMAN, ATP binding cassette sub family C (CFTR/MRP) member 8, ATP binding cassette transporter sub family C member 8 (1), ATP sensitive inward rectifier potassium channel 11, ATP-binding cassette sub-family C member 8, BIR, Beta cell inward rectifier subunit, CP2D6_HUMAN, CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, CYPIID6, Cholesterol 25-hydroxylase, Cytochrome P450 2D6, Cytochrome P450 family 2 subfamily D member 6, Cytochrome P450 family 2 subfamily D polypeptide 6, Cytochrome P450-DB1, Debrisoquine 4-hydroxylase, HHF 2, HHF1, HI, HRINS, IKATP, IRK 11, Inward rectifier K(+) channel Kir6.2, Inwardly rectifying potassium channel KIR6.2, KCNJ11, Kir 6.2, MGC133230, Microsomal monooxygenase, P450 DB1, P450C2D, PHHI, Potassium channel inwardly rectifing subfamily J member 11, Potassium channel, inwardly rectifying subfamily J member 11, Potassium inwardly rectifying channel J11, SUR1delta2, Sulfonylurea receptor (hyperinsulinemia), Sulfonylurea receptor 1, TNDM 3, TNDM2, Xenobiotic monooxygenase, flavoprotein-linked monooxygenase
- Chemical Structure
Lab
Chemical Structure - Diazoxide, KIR6.x (ATP-sensitive K+ channel) activator (AB120266)
2D chemical structure image of ab120266, Diazoxide, KIR6.x (ATP-sensitive K+ channel) activator
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CYP2D6 impacts various metabolic processes by serving as an enzyme that metabolizes approximately 25% of clinical drugs including antidepressants and antipsychotics. It forms part of the large P450 enzyme family but operates dynamically through its metabolic functions rather than as a consistent participant in stable complexes. In addition to drug metabolism CYP2D6 participates in the synthesis of cholesterol steroids and other lipids.
Pathways
CYP2D6 interacts with the drug metabolism pathway particularly affecting the metabolic fate of numerous pharmaceuticals and endogenous substrates. This enzyme contributes to the cytochrome P450 pathway which is pivotal in detoxifying chemicals and metabolizing various bioactive molecules. CYP2D6 functions alongside related cytochrome enzymes like CYP3A4 affecting the metabolism of overlapping substrates.
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Brain : a journal of neurology 145:2332-2346 PubMed35134125
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com